Qu Jian-Hui, Zhu Ming-Hua, Lin Jing, Ni Can-Rong, Li Fang-Mei, Zhu Zhi, Yu Guan-Zhen
Department of Pathology, Changhai Hospital, The Second Military Medical University, Shanghai, 200433, PR China.
Ai Zheng. 2004 May;23(5):502-7.
BACKGROUND & OBJECTIVE: A p53 response element like binding sequence, 5'-TGCC(G)T-TGCCT-3' was found at upstream of hepatitis B virus (HBV) enhancer I from 1047 to 1059 nucleotides after analyzing the HBV genome by a computer program in our previous work. It indicated that the sequence could specifically bind P53 protein in vitro by electrophoretic mobility shift assay (EMSA) and electrophoretic mobility supershift assay (EMSSA). This study was designed to further investigate the interaction between P53 and p53 response element like binding sequence at upstream of HBV enhancer I.
HBV x gene enhancer and promoter which contains p53 response element like binding sequence TGCGT-TGCCT was in upstream of CAT enzyme in pX-CAT reporter plasmid. Firstly, we designed a point mutation in pX-CAT which change TGCGT TGCCT into TGTAT. TGTAT by polymerase chain reaction (PCR) in order to damage the p53 response element like sequence. After pX-CAT or mutation pX-CAT (mpX-CAT) transfected alone or cotransfected with pCMVp53 into HepG2 hepatoma cell, CAT activity was assayed to confirm the correlation of p53 protein with this DNA sequence. In addition, an antisense sequence corresponding to the p53 response element like sequence in HBV was reconstructed into the pZeoSV2 vector (alpha pZeoXP) and transfected into HepG2.2.15 cell line to block the binding of P53 with this sequence, the stable transfected HepG2.2.15 cell was observed about P53/P21 expression, cell cycle distribution and apoptosis rates.
CAT enzyme of HepG2 had an higher expression in cotransfection with pCMVp53 and pX-CAT than alone pX-CAT (1.353 VS 0.738,P< 0.05), but it was lower in mpX-CAT(0.304) and pCMVp53 (0.402). Compared with the control group, P53/P21 expression and cell apoptosis rate decreased greatly in the stable transfected alpha pZeoXP HepG2.2.15 cell line (0.95% VS 7.84%), the cell number in S phase increased in the same cell line (16.37% VS 9.48%).
Reporter gene expression of pX-CAT in intracellular could be promoted by P53, which further suggest that P53 could bind TGCC(G)T-TGCCT in upstream of HBV enhancer I and induce a prolonged P53 half life. Subsequently, P53 and p21 protein (downstream gene of P53) would have a higher expression and stronger activity.
在前期工作中,我们通过计算机程序分析乙肝病毒(HBV)基因组,发现在HBV增强子I上游1047至1059核苷酸处存在一个类似p53反应元件的结合序列,即5'-TGCC(G)T-TGCCT-3'。电泳迁移率变动分析(EMSA)和电泳迁移率超变动分析(EMSSA)表明该序列在体外能特异性结合P53蛋白。本研究旨在进一步探讨P53与HBV增强子I上游类似p53反应元件结合序列之间的相互作用。
含有类似p53反应元件结合序列TGCGT-TGCCT的HBV x基因增强子和启动子位于pX-CAT报告质粒中CAT酶的上游。首先,我们通过聚合酶链反应(PCR)在pX-CAT中设计一个点突变,将TGCGT TGCCT变为TGTAT,以破坏类似p53反应元件的序列。将pX-CAT或突变的pX-CAT(mpX-CAT)单独转染或与pCMVp53共转染入HepG2肝癌细胞后,检测CAT活性以确认p53蛋白与该DNA序列的相关性。此外,将与HBV中类似p53反应元件序列对应的反义序列构建到pZeoSV2载体(α pZeoXP)中,并转染入HepG2.2.15细胞系,以阻断P53与该序列的结合,观察稳定转染的HepG2.2.15细胞中P53/P21表达、细胞周期分布及凋亡率。
与单独转染pX-CAT相比,HepG2细胞在与pCMVp53和pX-CAT共转染时CAT酶表达更高(1.353对0.738,P<0.05),但在mpX-CAT(0.304)和pCMVp53(0.402)共转染时较低。与对照组相比,稳定转染α pZeoXP的HepG2.2.15细胞系中P53/P21表达和细胞凋亡率显著降低(0.95%对7.84%),同一细胞系中S期细胞数量增加(16.37%对9.48%)。
P53可促进细胞内pX-CAT报告基因表达,这进一步表明P53可结合HBV增强子I上游的TGCC(G)T-TGCCT并诱导P53半衰期延长。随后,P53和p21蛋白(P53的下游基因)将有更高的表达和更强的活性。